HURA Latest News, Press Relases and Analysis

All

Press Releases

12 days ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

23 days ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences Discovery Research on Targeting the Delta Opioid Receptor (DOR) to Reprogram Myeloid-Derived Suppressor Cells (MDSCs) Selected for Oral Presentation at the 67th ASH Annual Meeting and Exposition

3 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. to Present at the 27th Annual H.C. Wainwright Global Investment Conference

3 months ago - By: The Motley Fool

TuHURA R&D Jumps 75% in Q2

3 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

4 months ago - By: Benzinga - Mentions: BABA

Florida Rep. Laurel Lee Sold Up to $265K Worth of Alibaba Gr Hldgs Stock

9 months ago - By: ACCESS Newswire

TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference

9 months ago - By: ACCESS Newswire

TuHURA Biosciences, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

3 months ago - By: Benzinga - Mentions: ARCT LIXT DERM EDIT ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

5 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

5 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences Completes Acquisition of Kineta

5 months ago - By: Stocktwits

Tuhura Biosciences Surges After-Hours As Investors Bet On Kineta Merger, Cancer Drug Pipeline

5 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. and Kineta, Inc. Stockholders Approve Proposed Merger and All Related Proposals

6 months ago - By: Halper Sadeh LLP - Mentions: VIGL

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders

6 months ago - By: TuHURA Biosciences, Inc.

FDA Removes Partial Clinical Hold on TuHURA Biosciences' Phase 3 Accelerated Approval Trial for IFx-2.0 in Advanced or Metastatic Merkel Cell Carcinoma

6 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Enters into $12.5 Million Equity Financing Transaction and Receives Additional $3.0 Million in Warrant Exercise Proceeds to Advance Its Pipeline of Novel Treatments to Overcome Primary Resistance to Cancer Immunotherapy

6 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences Presents IFx-Hu2.0 Trial-in-Progress Poster at the 2025 American Society of Clinical Oncology Annual Meeting

6 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update

7 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. to Present at the 3rd Annual H.C. Wainwright BioConnect Conference

7 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences and Kineta Present Updated Results from Kineta's Phase I-II Study of KVA12123 and TuHURA's Mechanism of IFx-Hu2.0 Responses After Anti-PD-1 Therapy Failure in Advanced Melanoma at the American Association for Cancer Research Annual

7 months ago - By: Yahoo Finance - Mentions: MTCH COMP NWG KMX ...

Match Group, Inc. (MTCH): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

7 months ago - By: Yahoo Finance - Mentions: COMP MTCH HFFG THTX ...

Is TuHURA Biosciences, Inc. (HURA) the Best Rising Penny Stock to Buy According to Analysts?

7 months ago - By: Yahoo Finance - Mentions: MBOT HFFG COMP RGLS ...

Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts?

7 months ago - By: Yahoo Finance - Mentions: ITRG GSC HES COMP ...

Is Integra Resources Corp. (ITRG) the Best Rising Penny Stock to Buy According to Analysts?

7 months ago - By: Yahoo Finance - Mentions: SATX MBOT COMP MTCH ...

Is Satixfy Communications Ltd. (SATX) the Best Rising Penny Stock to Buy According to Analysts?

7 months ago - By: Yahoo Finance - Mentions: HFFG CRL COMP MBOT ...

Is HF Foods Group Inc. (HFFG) the Best Rising Penny Stock to Buy According to Analysts?

8 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management

8 months ago - By: TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc. Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update

9 months ago - By: ACCESS Newswire

TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors

a year ago - By: Halper Sadeh LLC - Mentions: VTS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTS and HURA on Behalf of Shareholders

a year ago - By: Halper Sadeh LLC - Mentions: PFIE ML KANT

TUHURA BIOSCIENCES INC (HURA) Stock News

HURA Latest News, Press Relases and Analysis

TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

TuHURA Biosciences Discovery Research on Targeting the Delta Opioid Receptor (DOR) to Reprogram Myeloid-Derived Suppressor Cells (MDSCs) Selected for Oral Presentation at the 67th ASH Annual Meeting and Exposition

TuHURA Biosciences, Inc. to Present at the 27th Annual H.C. Wainwright Global Investment Conference

TuHURA R&D Jumps 75% in Q2

TuHURA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

Florida Rep. Laurel Lee Sold Up to $265K Worth of Alibaba Gr Hldgs Stock

TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference

TuHURA Biosciences, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

12 Health Care Stocks Moving In Wednesday's Intraday Session

TuHURA Biosciences, Inc. Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

TuHURA Biosciences Completes Acquisition of Kineta

Tuhura Biosciences Surges After-Hours As Investors Bet On Kineta Merger, Cancer Drug Pipeline

TuHURA Biosciences, Inc. and Kineta, Inc. Stockholders Approve Proposed Merger and All Related Proposals

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders

FDA Removes Partial Clinical Hold on TuHURA Biosciences' Phase 3 Accelerated Approval Trial for IFx-2.0 in Advanced or Metastatic Merkel Cell Carcinoma

TuHURA Biosciences, Inc. Enters into $12.5 Million Equity Financing Transaction and Receives Additional $3.0 Million in Warrant Exercise Proceeds to Advance Its Pipeline of Novel Treatments to Overcome Primary Resistance to Cancer Immunotherapy

TuHURA Biosciences Presents IFx-Hu2.0 Trial-in-Progress Poster at the 2025 American Society of Clinical Oncology Annual Meeting

TuHURA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update

TuHURA Biosciences, Inc. to Present at the 3rd Annual H.C. Wainwright BioConnect Conference

TuHURA Biosciences and Kineta Present Updated Results from Kineta's Phase I-II Study of KVA12123 and TuHURA's Mechanism of IFx-Hu2.0 Responses After Anti-PD-1 Therapy Failure in Advanced Melanoma at the American Association for Cancer Research Annual

Match Group, Inc. (MTCH): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

Is TuHURA Biosciences, Inc. (HURA) the Best Rising Penny Stock to Buy According to Analysts?

Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts?

Is Integra Resources Corp. (ITRG) the Best Rising Penny Stock to Buy According to Analysts?

Is Satixfy Communications Ltd. (SATX) the Best Rising Penny Stock to Buy According to Analysts?

Is HF Foods Group Inc. (HFFG) the Best Rising Penny Stock to Buy According to Analysts?

TuHURA Biosciences, Inc. Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management

TuHURA Biosciences, Inc. Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update

TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTS and HURA on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, ML, HURA, KANT on Behalf of Shareholders